These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 201523)
1. Relative sensitivity of three cell substrates to the Sabin poliovirus strains. Kado G Dev Biol Stand; 1976 Dec 13-15; 37():261-4. PubMed ID: 201523 [TBL] [Abstract][Full Text] [Related]
2. Replication of poliovirus (LSc 2 ab) in perfused cultures of MRC-5 diploid cells. Mann GF; de Mucha J Dev Biol Stand; 1976 Dec 13-15; 37():255-8. PubMed ID: 201522 [TBL] [Abstract][Full Text] [Related]
3. Improvement in the yield of oral poliovirus vaccine (Sabin strains) produced in human diploid cells. Mirchamsy H; Shafyi S; Bahrami S; Kamali M; Nazari P; Mahinpour M Dev Biol Stand; 1978; 41():183-5. PubMed ID: 753650 [TBL] [Abstract][Full Text] [Related]
4. Microevolution of type 3 Sabin strain of poliovirus in cell cultures and its implications for oral poliovirus vaccine quality control. Rezapkin GV; Norwood LP; Taffs RE; Dragunsky EM; Levenbook IS; Chumakov KM Virology; 1995 Aug; 211(2):377-84. PubMed ID: 7645242 [TBL] [Abstract][Full Text] [Related]
5. Production of high titer attenuated poliovirus strains on the serum-free PER.C6(®) cell culture platform for the generation of safe and affordable next generation IPV. Sanders BP; Oakes Ide L; van Hoek V; Liu Y; Marissen W; Minor PD; Wimmer E; Schuitemaker H; Custers JH; Macadam A; Cello J; Edo-Matas D Vaccine; 2015 Nov; 33(48):6611-6. PubMed ID: 26529068 [TBL] [Abstract][Full Text] [Related]
6. Preliminary results on the use of human diploid fibroblasts for inactivated polio virus vaccine production. Larsson B; Litwin J Dev Biol Stand; 1980; 46():241-7. PubMed ID: 6245000 [TBL] [Abstract][Full Text] [Related]
7. One amino acid change on the capsid surface of poliovirus sabin 1 allows the establishment of persistent infections in HEp-2c cell cultures. Pelletier I; Duncan G; Colbère-Garapin F Virology; 1998 Feb; 241(1):1-13. PubMed ID: 9454712 [TBL] [Abstract][Full Text] [Related]
8. Cell clones cured of persistent poliovirus infection display selective permissivity to the wild-type poliovirus strain Mahoney and partial resistance to the attenuated Sabin 1 strain and Mahoney mutants. Calvez V; Pelletier I; Couderc T; Pavio-Guédo N; Blondel B; Colbère-Garapin F Virology; 1995 Oct; 212(2):309-22. PubMed ID: 7571400 [TBL] [Abstract][Full Text] [Related]
9. Collaborative study for the establishment of the Ph. Eur. BRP for oral poliomyelitis vaccine (OPV) Batch 3 for use in the potency assay. Buchheit KH; Daas A; Stalder J Pharmeuropa Spec Issue Biol; 2002 Jun; 2002(1):67-91. PubMed ID: 12448032 [TBL] [Abstract][Full Text] [Related]
10. Genetic stability and mutant selection in Sabin 2 strain of oral poliovirus vaccine grown under different cell culture conditions. Taffs RE; Chumakov KM; Rezapkin GV; Lu Z; Douthitt M; Dragunsky EM; Levenbook IS Virology; 1995 Jun; 209(2):366-73. PubMed ID: 7778271 [TBL] [Abstract][Full Text] [Related]
11. Production and control of live oral poliovirus vaccine in WI-38 human diploid cells. Stones PB Dev Biol Stand; 1976 Dec 13-15; 37():251-3. PubMed ID: 1036401 [TBL] [Abstract][Full Text] [Related]
12. A perfusion culture system for virus vaccine manufacture in diploid cell cultures. Mann GF; de Mucha Macías J Bull Pan Am Health Organ; 1976; 10(3):205-11. PubMed ID: 187274 [TBL] [Abstract][Full Text] [Related]
13. Growth of vaccine strains of avian pneumovirus in different cell lines. Patnayak DP; Tiwari A; Goyal SM Avian Pathol; 2005 Apr; 34(2):123-6. PubMed ID: 16191692 [TBL] [Abstract][Full Text] [Related]
14. Protein-free culture of Vero cells: a substrate for replication of human pathogenic viruses. Cinatl J; Cinatl J; Rabenau H; Rapp J; Kornhuber B; Doerr HW Cell Biol Int; 1993 Sep; 17(9):885-95. PubMed ID: 8220316 [TBL] [Abstract][Full Text] [Related]
15. Comparative study of poliovirus excretion after vaccination of infants with two oral polio vaccines prepared on Vero cells or on primary monkey kidney cells. Mallet L; Pelloquin F; Brigaud M; Caudrelier P; Bandet R; Xueref C; Fuchs F; Gibelin N; Goldman C; Moulin JC; de Fraipont F; Montagnon B; Peyron L; Aymard M J Med Virol; 1997 May; 52(1):50-60. PubMed ID: 9131458 [TBL] [Abstract][Full Text] [Related]
16. Microevolution of Sabin 1 strain in vitro and genetic stability of oral poliovirus vaccine. Rezapkin GV; Chumakov KM; Lu Z; Ran Y; Dragunsky EM; Levenbook IS Virology; 1994 Jul; 202(1):370-8. PubMed ID: 8009849 [TBL] [Abstract][Full Text] [Related]
17. Serially subcultivated cells as substrates for poliovirus production for vaccine. von Seefried A; Chun JH Dev Biol Stand; 1981; 47():25-33. PubMed ID: 6262151 [TBL] [Abstract][Full Text] [Related]
18. Comparison of sensitivity of VERO cell line versus primary monkey kidney cells in the detection of residual live polio virus during and after inactivation. Montagnon BJ; Nicolas AJ; Fanget B; Peyron L Dev Biol Stand; 1981; 47():151-5. PubMed ID: 6262146 [TBL] [Abstract][Full Text] [Related]
19. Progress with inactivated poliovirus vaccines derived from the Sabin strains. Doi Y; Abe S; Yamamoto H; Horie H; Ohyama H; Satoh K; Tano Y; Ota Y; Miyazawa M; Wakabayashi K; Hashizume S Dev Biol (Basel); 2001; 105():163-9. PubMed ID: 11763324 [TBL] [Abstract][Full Text] [Related]
20. Use of MDCK cells for production of live attenuated influenza vaccine. Liu J; Shi X; Schwartz R; Kemble G Vaccine; 2009 Oct; 27(46):6460-3. PubMed ID: 19559113 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]